What is the average price target for GRI BIO INC (GRI) stock?
6 analysts have analysed GRI and the average price target is 656.88 USD. This implies a price increase of 27733.9% is expected in the next year compared to the current price of 2.36.
GRI BIO INC (GRI) Forecast, Price Target & Analyst Ratings
NASDAQ:GRI • US3622AW5029
Current stock price
2.36 USD
-0.25 (-9.58%)
At close:
2.4 USD
+0.04 (+1.69%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for GRI BIO INC (GRI).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 13, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$10.15
- Revenue Estimate
Price Target Details & History
Consensus Price Target and Range
Mean target
$656.88
Upside
+ 27,733.90%
From current price of $2.36 to mean target of $656.88, Based on 6 analyst forecasts
Low
$282.80
Median
$656.88
High
$1,058.40
Price Target Revisions
1 Month
0.00%
3 Months
528.29%
Price Target Summary
6 Wall Street analysts provided a forecast for the next 12 months for GRI. The average price target is 656.88 USD. This implies a price increase of 27733.9% is expected in the next year compared to the current price of 2.36.
The average price target has been revised upward by 528.29% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
80.00%
GRI was analyzed by 6 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about GRI.
In the previous month the buy percentage consensus was at a similar level.
GRI was analyzed by 6 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-11 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-12-08 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-09-22 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-06-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-05-27 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2025-04-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-09 | HC Wainwright & Co. | Initiate | Buy |
| 2024-12-05 | Ascendiant Capital | Maintains | Buy -> Buy |
| 2024-10-08 | Ascendiant Capital | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 13, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$10.15
- Revenue Estimate
- Revenue Q2Q
- N/A
- EPS Q2Q
- 93.75%
- Number of Analysts
- 3
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
49.47%
EPS (3 Months)
-1,041.48%
Next Earnings Summary
GRI is expected to report earnings on 5/13/2026. The consensus EPS estimate for the next earnings is -10.15 USD and the consensus revenue estimate is 0 USD.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 100K | -100.00% | N/A | N/A | ||||||||
| EBITDA YoY % growth | -4.313M | -3.139M 27.23% | -4.713M -50.16% | N/A -94.65% | N/A 26.73% | N/A -69.34% | -9.999M 27.65% | -13.534M -64.33% | -15.251M -12.69% | -17.574M -15.23% | -19.695M -12.07% | |
| EBIT YoY % growth | -4.314M | -3.154M 26.87% | -4.788M -51.79% | -7.742M -93.38% | N/A 25.18% | N/A -64.36% | -9.283M 27.64% | -12.985M -57.59% | -12.474M 3.94% | -17.574M -40.89% | -19.695M -12.07% | |
| Operating Margin | N/A | N/A | -4,788.00% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -1,548,720.26 | N/A | N/A | -1,360.55 | -166.43 74.16% | -38.62 89.01% | -38.38 0.63% | -10.18 73.47% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -10.15 93.75% | -9.86 73.11% | -9.58 73.26% | -9.31 92.02% |
| Revenue Q2Q % growth | ||||
| EBITDA Q2Q % growth | -2.929M 3.97% | -2.929M -1.17% | -3.232M 3.87% | -3.737M -40.49% |
| EBIT Q2Q % growth | -2.424M 20.55% | -2.424M 16.33% | -2.424M 27.96% | -2.424M 9.01% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
25.38%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
-23.71%
EBIT Next 5 Year
-20.69%
GRI BIO INC / GRI Forecast FAQ
When does GRI BIO INC (GRI) report earnings?
GRI BIO INC (GRI) will report earnings on 2026-05-13.
Can you provide the consensus estimates for GRI BIO INC next earnings?
The consensus EPS estimate for the next earnings of GRI BIO INC (GRI) is -10.15 USD and the consensus revenue estimate is 0 USD.
How do analysts rate GRI BIO INC (GRI)?
The consensus rating for GRI BIO INC (GRI) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.